Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7705 Poplar Ave
Ste 220
Germantown, TN 38138Phone+1 901-516-6792Fax+1 901-266-6422
Summary
- Martin Fleming, MD, is a surgical oncologist based in Memphis, TN, with subspecialty expertise in the surgical treatment of melanoma and other cutaneous malignancies, soft tissue sarcoma, and breast cancer. He completed his surgery residency at the University of Texas Southwestern Medical Center in 1991 and graduated from the University of Tennessee Health Science Center College of Medicine in 1986. He completed his surgical oncology fellowship at the Medical College of Virginia. Dr. Fleming has considerable experience in breast surgery and non-breast surgical oncology. His recent publications focus on molecular aspects of breast cancer and melanoma, having been featured in prestigious journals such as Proceedings of the National Academy of Sciences and Cell Reports. Notable recognition includes being a Fellow of the American College of Surgeons (FACS).
Education & Training
- University of Texas Southwestern Medical CenterResidency, Surgery, 1986 - 1991
- University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
- MS State Medical License 2013 - 2025
- TN State Medical License 1993 - 2025
- AR State Medical License 2013 - 2021
- TX State Medical License 1987 - 1991
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsA molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity.Sarah Asemota, Wendy Effah, Jeremiah Holt, Daniel Johnson, Linnea Cripe
Proceedings of the National Academy of Sciences of the United States of America. 2024-10-01 - 9 citationsNCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.Susan M Swetter, Douglas Johnson, Mark R Albertini, Christopher A Barker, Sarah Bateni
Journal of the National Comprehensive Cancer Network. 2024-07-01 - 5 citationsIdentification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype.Sarah Asemota, Wendy Effah, Kirsten L Young, Jeremiah Holt, Linnea Cripe
Cell Reports. 2023-12-26
Press Mentions
- UTHSC Extends Reach to Advance Health Equity Locally and GloballyJune 4th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: